Fate Therapeutics (FATE)
(Delayed Data from NSDQ)
$3.87 USD
-0.13 (-3.25%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $3.91 +0.04 (1.03%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -0.42 |
EPS Last Quarter | -0.33 |
Last EPS Surprise | 29.79% |
ABR | 2.45 |
Earnings ESP
|
4.33% |
---|---|
Current Year | -1.73 |
Next Year | -1.69 |
EPS (TTM) | -1.71 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.88M | 1.08M | 9.84M | 3.60M |
# of Estimates | 5 | 4 | 7 | 3 |
High Estimate | 1.00M | 1.60M | 11.00M | 4.00M |
Low Estimate | 0.70M | 0.80M | 8.70M | 3.20M |
Year ago Sales | 1.94M | 1.68M | 63.53M | 9.84M |
Year over Year Growth Est. | -54.64% | -36.01% | -84.51% | -63.42% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.42 | -0.42 | -1.73 | -1.69 |
# of Estimates | 9 | 7 | 11 | 10 |
Most Recent Consensus | -0.40 | -0.41 | -2.62 | -2.11 |
High Estimate | -0.39 | -0.36 | -1.21 | -0.85 |
Low Estimate | -0.46 | -0.48 | -2.62 | -2.11 |
Year ago EPS | -0.46 | -0.45 | -1.64 | -1.73 |
Year over Year Growth Est. | 8.70% | 6.67% | -5.49% | 1.87% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 2 | 2 | 1 |
Up Last 60 Days | 7 | 7 | 9 | 7 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.42 | -0.42 | -1.73 | -1.69 |
7 Days Ago | -0.42 | -0.42 | -1.73 | -1.69 |
30 Days Ago | -0.43 | -0.43 | -1.76 | -1.34 |
60 Days Ago | -0.48 | -0.48 | -1.90 | -1.42 |
90 Days Ago | -0.48 | -0.48 | -1.90 | -1.42 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.41 | -0.41 | -1.61 | -1.79 |
Zacks Consensus Estimate | -0.42 | -0.42 | -1.73 | -1.69 |
Earnings ESP | 4.33% | 3.04% | 7.03% | -5.37% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.33 | -0.47 | -0.45 | -0.46 | NA |
Estimate | -0.47 | -0.47 | -0.57 | -0.59 | NA |
Difference | 0.14 | 0.00 | 0.12 | 0.13 | 0.10 |
Surprise | 29.79% | 0.00% | 21.05% | 22.03% | 18.22% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more